Comment on

• Diagnostic Utility of Serum and Urinary Metabolite Analysis in Patients with Interstitial Cystitis/Painful Bladder Syndrome.

  Kim J, De Hoedt A, Wiggins E, Haywood K, Jin P, Greenwood B, Narain NR, Tolstikov V, Bussberg V, Barbour KE, Kiebish MA, Freedland SJ, Anger JT. Kim J, et al. Urology. 2021 Nov;157:85-92. doi: 10.1016/j.urology.2021.05.005. Epub 2021 May 17. Urology. 2021. PMID: 34010675 Free PMC article.
• Immediate Artificial Urinary Sphincter (AUS) Reactivation at the Time of Urethral Cuff Exchange is Not Associated with Increased Erosion Rate.

  Rabinowitz MJ, Haney NM, Liu JL, Dani H, Cohen AJ, Wright EJ. Rabinowitz MJ, et al. Urology. 2021 Nov;157:253-256. doi: 10.1016/j.urology.2021.07.021. Epub 2021 Jul 31. Urology. 2021. PMID: 34343563
• Same Day Discharge Versus Overnight Observation Protocols - Similar Outcomes Following Artificial Urinary Sphincter Surgery.

  Dropkin BM, Sanders SC, Kavoussi M, Shaaban A, Joice GA, Hudak SJ, Lotan Y, Morey AF. Dropkin BM, et al. Urology. 2021 Nov;157:206-210. doi: 10.1016/j.urology.2021.08.016. Epub 2021 Aug 23. Urology. 2021. PMID: 34437897
• Evidence for Early Cyclosporine Treatment for Hunner Lesion Interstitial Cystitis.

  Vollstedt A, Tennyson L, Turner K, Hasenau D, Saon M, McCartney T, Beck D, Gilleran J, Peters K. Vollstedt A, et al. Female Pelvic Med Reconstr Surg. 2022 Jan 1;28(1):e1-e5. doi: 10.1097/SPV.0000000000001108. Female Pelvic Med Reconstr Surg. 2022. PMID: 34608034
• Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance.

  Poole RL, Dale M, Morgan H, Oladapo T, Brookfield R, Morris R. Poole RL, et al. Appl Health Econ Health Policy. 2022 May;20(3):305-313. doi: 10.1007/s40258-021-00701-0. Epub 2021 Dec 29. Appl Health Econ Health Policy. 2022. PMID: 34964090 Free PMC article. Review.